References
- Swaney MH, Kalan LR. Living in your skin: microbes, molecules, and mechanisms. Infect Immun. 2021;89(4):e00695–e00720. doi:10.1128/IAI.00695-20
- Bollag WB, Aitkens L, White J, et al. HyndmanAquaporin-3 in the epidermis: more than skin deep. Am J Physiol Cell Physiol. 2020;318(6):C1144–C1153. doi:10.1152/ajpcell.00075.2020
- El-Serafi AT, El-Serafi I, Steinvall I, et al. A systematic review of keratinocyte secretions: a regenerative perspective. Int J Mol Sci. 2022;23(14):7934. doi:10.3390/ijms23147934
- Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063–1072. doi:10.1111/j.1600-0625.2008.00786.x
- Tricarico PM, Mentino D, Marco AD, et al. Aquaporins are one of the critical factors in the disruption of the skin barrier in inflammatory skin diseases. Int J Mol Sci. 2022;23:4020. doi:10.3390/ijms23074020
- Ishibashi K, Kondo S, Hara S, et al. The evolutionary aspects of aquaporin family. Am J Physiol Regul Integr Comp Physiol. 2011;300(3):R566–R576. doi:10.1152/ajpregu.90464.2008
- Verkman AS, Mitra AK. Structure and function of aquaporin water channels. Am J Physiol Renal Physiol. 2000;278(1):13–28. doi:10.1152/ajprenal.2000.278.1.F13
- Chikuma MH, Verkman AS. Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing. J Mol Med. 2008;86(2):221–231. doi:10.1007/s00109-007-0272-4
- Hara M, Ma T, Verkman AS. Selectively reduced glycerol in skin of aquaporin-3-deficient mice may account for impaired skin hydration, elasticity, and barrier recovery. J Biol Chem. 2002;277(48):46616–46621. doi:10.1074/jbc.M209003200
- Qin H, Zheng X, Zhong X, et al. Aquaporin-3 in keratinocytes and skin: its role and interaction with phospholipase D2. Arch Biochem Biophys. 2011;508(2):138–143. doi:10.1016/j.abb.2011.01.014
- Rios JL. Chemical constituents and pharmacological properties of Poria cocos. Planta Med. 2011;77(7):681–691. doi:10.1055/s-0030-1270823
- Lee SM, Lee YJ, Yoon JJ, et al. Effect of Poria cocos on hypertonic stress-induced water channel expression and apoptosis in renal collecting duct cells. J Ethnopharmacol. 2012;141(1):368–376. doi:10.1016/j.jep.2012.02.048
- Feng YL, Lei P, Tian T, et al. Diuretic activity of some fractions of the epidermis of Poria cocos. J Ethnopharmacol. 2013;150(3):1114–1118. doi:10.1016/j.jep.2013.10.043
- Bae MJ, See HJ, Choi G, et al. Regulatory T cell induced by poria cocos bark exert therapeutic effects in murine models of atopic dermatitis and food allergy. Mediators Inflamm. 2016;2016:3472608. doi:10.1155/2016/3472608
- Tian H, Liu Z, Pu Y, et al. Immunomodulatory effects exerted by Poria cocos polysaccharides via TLR4/TRAF6/NF-κB signaling in vitro and in vivo. Biomed Pharmacother. 2019;112:108709. doi:10.1016/j.biopha.2019.108709
- Kang KY, Hwang YH, Lee SJ, et al. Verification of the functional antioxidant activity and antimelanogenic properties of extract of Poria cocos mycelium fermented with Freeze-dried plum powder. Int J Biomater. 2019;2019:9283207. doi:10.1155/2019/9283207
- Xia B, Zhou Y, Tan HS, et al. Advanced ultra-performance liquid chromatography-photodiode array-quadrupole time-of-flight mass spectrometric methods for simultaneous screening and quantification of triterpenoids in Poria cocos. Food Chem. 2014;152:237–244. doi:10.1016/j.foodchem.2013.11.151
- Tai T, Akita Y, Kinoshita K, et al. Anti-emetic principles of Poria cocos. Planta Med. 1995;61(6):527–530. doi:10.1055/s-2006-959363
- Giner EM, Manez S, Recio MC, et al. In vivo studies on the anti-inflammatory activity of pachymic and dehydrotumulosic acids. Planta Med. 2000;66(3):221–227. doi:10.1055/s-2000-8563
- Kaminaga T, Yasukawa K, Kanno H, et al. Inhibitory effects of lanostane-type triterpene acids, the components of Poria cocos, on tumor promotion by 12-O-Tetradecanoylphorbol-13-acetate in two-stage carcinogenesis in mouse skin. Oncology. 1996;53(5):382–385. doi:10.1159/000227592
- Gapter L, Wang Z, Glinski J, et al. Induction of apoptosis in prostate cancer cells by pachymic acid from Poria cocos. Biochem Biophys Res Commun. 2005;332(4):1153–1161. doi:10.1016/j.bbrc.2005.05.044
- Li G, Xu ML, Lee CS, et al. Cytotoxicity and DNA topoisomerases inhibitory activity of constituents from the sclerotium of Poria cocos. Arch Pharm Res. 2004;27(8):829–833. doi:10.1007/BF02980174
- Boury JM, Sougrata R, Tailhardat M, et al. Expression and function of aquaporins in human skin: is aquaporin-3 just a glycerol transporter? Biochim Biophys Acta. 2006;1758(8):1034–1042. doi:10.1016/j.bbamem.2006.06.013
- Baey AD, Lanzavecchia A. The role of aquaporins in dendritic cell micropinocytosis. J Exp Med. 2000;191(4):743–748. doi:10.1084/jem.191.4.743
- Zhang Z, Xu P, Xie Z, et al. Downregulation of AQP2 in the anterior vaginal wall is associated with the pathogenesis of female stress urinary incontinence. Mol Med Rep. 2017;16(3):3503–3509. doi:10.3892/mmr.2017.7014
- Aburada T, Ikarashi N, Kagami M, et al. Byakkokaninjinto prevents body water loss by increasing the expression of kidney aquaporin-2 and skin aquaporin-3 in KKAy mice. Phytother Res. 2011;25(6):897–903. doi:10.1002/ptr.3358
- Patel R, Heard LK, Chen X, et al. Aquaporins in the skin. Adv Exp Med Biol. 2017;969:173–191. doi:10.1007/978-94-024-1057-0_11
- Malale K, Fu J, Qiu L, et al. Hypoxia-induced aquaporin-3 changes hepatocellular carcinoma cell sensitivity to sorafenib by activating the PI3K/Akt signaling pathway. Cancer Manag Res. 2020;12:4321–4333. doi:10.2147/CMAR.S243918
- Xu H, Xu Y, Zhang W, et al. Aquaporin-3 positively regulates matrix metalloproteinases via PI3K/AKT signal pathway in human gastric carcinoma SGC7901 cells. J Exp Clin Cancer Res. 2011;30(1):86. doi:10.1186/1756-9966-30-86
- Chandrashekar L, Rajappa M, Rajendiran KS, et al. Is vitiligo associated with systemic aquaporin-3 deficiency? Postepy Dermatol Alergol. 2021;38(2):156–158. doi:10.5114/ada.2021.104291
- Rodríguez A, Catalán V, Ambrosi JG, et al. Insulin- and leptin-mediated control of aquaglyceroporins in human adipocytes and hepatocytes is mediated via the PI3K/Akt/mTOR signaling cascade. J Clin Endocrinol Metab. 2011;96(4):E586–E597. doi:10.1210/jc.2010-1408
- Wang W, Geng X, Lei L, et al. Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease. FASEB J. 2019;33(5):6185–6196. doi:10.1096/fj.201801338RRR
- Hou SY, Li YP, Wang JH, et al. Aquaporin-3 inhibition reduces the growth of NSCLC cells induced by hypoxia. Cell Physiol Biochem. 2016;38(1):129–140. doi:10.1159/000438615
- Fingar DC, Blenis J. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene. 2004;23(18):3151–3171. doi:10.1038/sj.onc.1207542
- Sarbassov DD, Guertin DA, Ali SM, et al. Phosphorylation and regulation of Akt/PKB by the Rictor-mTOR complex. Science. 2005;307(5712):1098–1101. doi:10.1126/science.1106148
- Ding X, Bloch W, Iden S, et al. mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation. Nat Commun. 2016;7(1):13226. doi:10.1038/ncomms13226
- Buerger C, Shirsath N, Lang V, et al. Inflammation dependent mTORC1 signaling interferes with the switch from keratinocyte proliferation to differentiation. PLoS One. 2017;12(7):e0180853. doi:10.1371/journal.pone.0180853
- Carr TD, DiGiovanni J, Lynch CJ, et al. Inhibition of mammalian target of rapamycin (mTOR) suppresses UVB-induced keratinocyte proliferation and survival. Cancer Prev Res. 2012;5(12):1394–1404. doi:10.1158/1940-6207.CAPR-12-0272-T
- Yang B, Xu QY, Guo CY, et al. MHY1485 ameliorates UV-induced skin cell damages via activating mTOR-Nrf2 signaling. Oncotarget. 2017;8(8):12775–12783. doi:10.18632/oncotarget.14299